Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis

Pediatric Nephrology

Volumn 22, Issue 8, 2007, Pages 1215-1218

  Imaizumi, Tomoko ^a   Kawasaki, Yukihiko ^a   Matsuura, Hiromi ^a   Matsumoto, Ayumi ^a   Takano, Kei ^a   Suyama, Kazuhide ^a   Hashimoto, Koichi ^a   Suzuki, Hitoshi ^a   Hosoya, Mitsuaki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Child; Cyclosporine; Focal segmental glomerulosclerosis; Leukoencephalopathy; Nephrotic syndrome

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MIZORIBINE; RIBONUCLEOSIDE;

ARTICLE; BRAIN DISEASE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG PULSE THERAPY; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HUMAN; MALE; NEPHROTIC SYNDROME; PATHOLOGY; PLASMAPHERESIS; PRESCHOOL CHILD; RADIOGRAPHY; TIME; TREATMENT OUTCOME;

BRAIN DISEASES; CHILD, PRESCHOOL; CYCLOSPORINE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME; PLASMAPHERESIS; PULSE THERAPY, DRUG; RIBONUCLEOSIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548394621     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-007-0461-y     Document Type: Article

References (13)

1. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213-218
2. Brown CR, Cameron JS, Turner DR, Chantler C, Ogg CS, Williams DG, BewickM(1978) Focal segmental glomerulosclerosis with rapid decline in renal function (malignant FSGS). Clin Nephrol 10:51-61
3. Korbet SM (1998) Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 9:1333-1340
4. Korbet SM, Schwartz MM, Lewis EL (1998) Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. Am J Kidney Dis 23:773-783
5. Belson A, Yorgin PD, Al-Uzri AY, Salvatierra O, Higgins J, Alexander SR (2001) Long-term plasmapheresis and protein A column treatment of recurrent FSGS. Pediatr Nephrol 16:985-989
6. Diasio RB, Lo Buglio AF (1996) Immunomodulators: Immunosuppressive agents and immunostimulants. In: Hardman JG, Goodman E (eds) Goodman & Gilman's the pharmacological basis of therapeutics, vol 52, 9th edn. McGraw-Hill, New York, pp 1291-1308
7. Meyrier A (2005) Treatment of focal segmental glomerulosclerosis. Expert Opin Pharmacother 6:1539-1549
8. Hughes SE, Gruber SA (1996) New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 36:1081-1092
9. Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, Tanizawa T, Wada H, Maki S, Pediatric Mizoribine Study Group in Japan (2000) A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 58:317-324
10. Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H (2005)Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome. Pediatr Nephrol 20:96-98
11. Kawasaki Y, Hosoya M, Kobayashi S, Ohara S, Onishi N, Takahashi A, Isome M, Suzuki H (2005) Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome. Nephrol Dial Transplant 20:2243-2247
12. Ohtomo Y, Fujinaga S, Takada M, Murakami H, Akashi S, Shimuzu T, Kaneko K, Yamashiro Y (2005) High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephritic syndrome with cyclosporin nephrotoxicity. Pediatr Nephrol 20:1744-1749
13. Hinchey J, Chaves C, Appignani B, Breen J, Pao L,Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494-500